7KCJ

The crystal structure of the translation initiation factor EIF4E5 from Leishmania major

Summary for 7KCJ

• Entry DOI: 10.2210/pdb7kcj/pdb
• Descriptor: Eukaryotic translation initiation factor 4E type 5 (2 entities in total)
• Functional Keywords: translation
• Biological source: Leishmania major
• Total number of polymer chains: 2
• Total formula weight: 50839.96

Authors

Lima, G.B.,Guimaraes, B.G. (deposition date: 2020-10-05, release date: 2021-06-02, Last modification date: 2024-04-03)

Primary citation

de Lima, G.B.,de Lima Cavalcanti, T.Y.V.,de Brito, A.N.A.L.M.,de Assis, L.A.,Andrade-Vieira, R.P.,Freire, E.R.,da Silva Assuncao, T.R.,de Souza Reis, C.R.,Zanchin, N.I.T.,Guimaraes, B.G.,de-Melo-Neto, O.P.
The translation initiation factor EIF4E5 from Leishmania: crystal structure and interacting partners.
Rna Biol., 18:2433-2449, 2021

PubMed Abstract: The mRNA cap-binding protein, eIF4E, mediates the recognition of the mRNA 5' end and, as part of the heterotrimeric eIF4F complex, facilitates the recruitment of the ribosomal subunits to initiate eukaryotic translation. Various regulatory events involving eIF4E and a second eIF4F subunit, eIF4G, are required for proper control of translation initiation. In pathogenic trypanosomatids, six eIF4Es and five eIF4Gs have been described, several forming different eIF4F-like complexes with yet unresolved roles. EIF4E5 is one of the least known of the trypanosomatid eIF4Es and has not been characterized in species. Here, we used immunoprecipitation assays, combined with mass-spectrometry, to identify major EIF4E5 interacting proteins in . A constitutively expressed, HA-tagged, EIF4E5 co-precipitated mainly with EIF4G1 and binding partners previously described in , EIF4G1-IP, RBP43 and the 14-3-3 proteins. In contrast, no clear co-precipitation with EIF4G2, also previously reported, was observed. EIF4E5 also co-precipitated with protein kinases, possibly associated with cell-cycle regulation, selected RNA binding proteins and histones. Phosphorylated residues were identified and mapped to the -specific C-terminal end. Mutagenesis of the tryptophan residue (W53) postulated to mediate interactions with protein partners or of a neighbouring tryptophan conserved in (W45) did not substantially impair the identified interactions. Finally, the crystal structure of EIF4E5 evidences remarkable differences in the eIF4G interfacing region, when compared with human eIF4E-1 and with its orthologue. Mapping of its C-terminal end near the cap-binding site also imply relevant differences in cap-binding function and/or regulation.

PubMed: 33945405
DOI: 10.1080/15476286.2021.1918919

Experimental method

X-RAY DIFFRACTION (1.997 Å)